FORMULATIONS OF TRIPHENYL CALCILYTIC COMPOUNDS

The present disclosure provides tablet formulations including a triphenyl calcilytic compound for the treatment of autosomal dominant hypocalcemia (ADH), where the compound is represented by formula (I):a solvate, a hydrate, a pharmaceutically acceptable salt, or a combination thereof.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PRASAD, Leena, KOMEYLI, Ali, SRIDHAR, Ananth, SINHA, Uma
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure provides tablet formulations including a triphenyl calcilytic compound for the treatment of autosomal dominant hypocalcemia (ADH), where the compound is represented by formula (I):a solvate, a hydrate, a pharmaceutically acceptable salt, or a combination thereof.